1-3 of 3
Sara Mastaglio
Close
Sort by
Journal Articles

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB

Daniela Clerici, Laura Galli, Raffaella Greco, Anna P. Lugli, Federico Erbella, Marco Ripa, Chiara Tassan Din, Rosamaria Nitti, Fabio Giglio, Sara Mastaglio, Francesca Lorentino, Elisabetta Xue, Francesca Farina, Carmine Liberatore, Andrea Poli, Silvia Carletti, Maria T. Lupo Stanghellini, Matteo G. Carrabba, Andrea A. Assanelli, Annalisa Ruggeri, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Nicasio Mancini, Paolo Scarpellini, Fabio Ciceri, Antonella Castagna, Chiara Oltolini
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1621–1634.
https://doi.org/10.1182/bloodadvances.2022008226
Published: 2023
Includes: Supplemental data
Journal Articles

Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation

Francesca Lorentino, Elisabetta Xue, Sara Mastaglio, Fabio Giglio, Daniela Clerici, Francesca Farina, Simona Piemontese, Alessandro Bruno, Lorenzo Lazzari, Annalisa Ruggeri, Elena Guggiari, Francesca Lunghi, Andrea A. Assanelli, Sarah Marktel, Magda Marcatti, Matteo G. Carrabba, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Fabio Ciceri, Raffaella Greco, Maria Teresa Lupo-Stanghellini
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3053–3057.
https://doi.org/10.1182/bloodadvances.2021006213
Published: 2022
Includes: Supplemental data
Journal Articles

Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy

Sara Mastaglio, Eric Wong, Travis Perera, Jane Ripley, Piers Blombery, Mark J. Smyth, Rachel Koldej, David Ritchie
Journal: Blood Advances
Blood Adv (2018) 2 (4): 335–346.
https://doi.org/10.1182/bloodadvances.2017015230
Published: 2018
Includes: Supplemental data